Wang Miao, Zhang Lei, Hou Huimin, Gu Tao, Shen Cheng, Ding Xin, Zhang Jintao, Wang Xuan, Wang Jianlong, Wang Jianye, Liu Ming
Department of Urology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Graduate School of Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
Transl Cancer Res. 2021 Dec;10(12):5430-5436. doi: 10.21037/tcr-21-1757.
Prostate cancer (PCa) is the most common malignancy among men worldwide. High-intensity focused ultrasound (HIFU) is a focal therapeutic strategy for low- to intermediate-risk PCa with a low risk of complications. However, lesions located in the anterior urethral zone are challenging to treat with this approach because it is difficult to avoid urethral injury during HIFU therapy, which might further cause urethral stricture and symptoms related to bladder outlet obstruction (BOO). Here, we present the case of a 79-year-old male with elevated prostate-specific antigen (PSA) levels for over 1 year. Multiparametric magnetic resonance imaging revealed a 1.8 cm × 1.0 cm mass covering an area of the anterior urethral zone. Histopathological examination revealed an International Society of Urological Pathology grade group 3 acinar adenocarcinoma. Given the patient's request for functional preservation, a magnetic resonance-guided focused ultrasound surgery was performed. During the operation, a urethra-sparing approach was utilized by administering proper energy and adjusting the sequence of the sonications. The patient developed urinary retention after catheter removal less than 48 h after the treatment, which resolved after removal of the second catheter a week later. On a follow-up visit 3 months after the treatment, evaluation by the level of PSA and multiparametric magnetic resonance imaging showed no recurrence of PCa. No significant changes in the International Prostate Symptom Score and Quality of Life score were found compared to baseline scores. With proper adjustment, magnetic resonance-guided focused ultrasound surgery could be safely used for urethra-sparing surgeries for PCa lesions in the anterior urethral zone, without influencing post-treatment urination. The indwelling time of the catheter should be extended appropriately for full recovery from treatment-related prostatic edema around the prostatic urethra to avoid urinary retention.
前列腺癌(PCa)是全球男性中最常见的恶性肿瘤。高强度聚焦超声(HIFU)是一种针对低至中风险PCa的局部治疗策略,并发症风险较低。然而,位于前尿道区的病变采用这种方法治疗具有挑战性,因为在HIFU治疗期间难以避免尿道损伤,这可能进一步导致尿道狭窄和与膀胱出口梗阻(BOO)相关的症状。在此,我们报告一例79岁男性,其前列腺特异性抗原(PSA)水平升高超过1年。多参数磁共振成像显示一个1.8 cm×1.0 cm的肿块,覆盖前尿道区的一个区域。组织病理学检查显示为国际泌尿病理学会3级腺泡腺癌。鉴于患者对功能保留的要求,进行了磁共振引导下的聚焦超声手术。手术过程中,通过给予适当能量并调整超声顺序采用了保留尿道的方法。患者在治疗后不到48小时拔除导尿管后出现尿潴留,一周后拔除第二根导尿管后缓解。治疗后3个月的随访中,通过PSA水平和多参数磁共振成像评估显示PCa无复发。与基线评分相比,国际前列腺症状评分和生活质量评分无显著变化。通过适当调整,磁共振引导下的聚焦超声手术可安全用于前尿道区PCa病变的保留尿道手术,且不影响治疗后的排尿。应适当延长导尿管留置时间,以使前列腺尿道周围与治疗相关的前列腺水肿完全恢复,避免尿潴留。